Diana I. Pérez-Román

Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis

Jorge Rojas‐Serrano, Denisse Herrera-Bringas, Diana I. Pérez-Román et al. · Clinical Rheumatology · 2017 · 150 citations

Medicine, Immunology, Internal Medicine +14

Timing of onset affects arthritis presentation pattern in antisyntethase syndrome.

Miguel Á. González‐Gay, Carlomaurizio Montecucco, Albert Selva-O’Callaghan et al. · PubMed · 2018 · 57 citations · Full text

Medicine, Internal Medicine, Autoimmunity +11

Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia with autoimmune features (IPAF)

Mayra Mejía, Denisse Herrera-Bringas, Diana I. Pérez-Román et al. · Respiratory Medicine · 2016 · 51 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Evolution of Pulmonary Function in a Cohort of Patients with Interstitial Lung Disease and Positive for Antisynthetase Antibodies

Montserrat I. González-Pérez, José Guillermo Mejía-Hurtado, Diana I. Pérez-Román et al. · The Journal of Rheumatology · 2019 · 42 citations

Medicine, Clinical Sciences, Internal Medicine +13

Rheumatoid arthritis-related interstitial lung disease (RA-ILD): a possible association between disease activity and prognosis

Jorge Rojas‐Serrano, Mayra Mejía, Pedro A. Rivera-Matias et al. · Clinical Rheumatology · 2022 · 31 citations

Medicine, Immunology, Internal Medicine +16